EMEA-002875-PIP02-24

Human medicines European public assessment report (EPAR): Grepid, clopidogrel, Date of authorisation: 27/07/2009, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR): Nustendi, bempedoic acid,ezetimibe, Date of authorisation: 27/03/2020, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Nilemdo, bempedoic acid, Date of authorisation: 01/04/2020, Revision: 9, Status: Authorised

EMA starts review of sodium oxybate in alcohol dependence

Opinion/decision on a Paediatric investigation plan (PIP): Brukinsa, zanubrutinib, decision type: W: decision granting a waiver in all age groups for all conditions or indications, therapeutic area: Blood and lymphatic system disorders, PIP number: P/0226/2024

EMEA-003613-PIP01-24

EMEA-003611-PIP01-24

EMEA-003606-PIP01-24

Human medicines European public assessment report (EPAR): Memantine Merz, memantine hydrochloride, Date of authorisation: 22/11/2012, Revision: 9, Status: Authorised